Grant T. Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Grant T. Liu has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Miki
Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia 19104, USA
3 shared publications John C. Haselgrove
From the Children's Hospital of Philadelphia, Functional MRI Research Unit, and the University of Pennsylvania School of Medicine, Philadelphia
2 shared publications- Amy M. Lavery
Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA/Department of Social and Behavioral Sciences, College of Public Health, Temple University, Philadelphia, PA, USA
1 shared publication - Amy Tara Waldman
Division of Neurology, Children's Hospital of Philadelphia, PA
1 shared publication Ann-Christine Duhaime
Department of Neurosurgery (G.T.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
1 shared publicationAnna Janss
Service of Pathology (J.C.G.), Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2018
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 9 (1) , 130
Pseudotumor cerebri comorbid with meningioma: A review and case series
Pseudotumor cerebri (PTC), which has a prevalence in the general population of 1 to 2 out of 100,000, presents with raised intracranial pressure (ICP) but generally lacks a space occupying lesion. Patient 1 is a 32-year-old woman with a history of multiple meningiomas. Upon presentation to our institution, her clinical exam was notable for a right sixth nerve palsy. An integrated diagnosis of PTC was made and shunting for the cerebrospinal fluid (CSF) diversion was recommended. Approximately 6 weeks after surgery, the patient exhibited complete symptom resolution and discontinued all medications. Patient 2 is a 40-year-old woman with history of meningioma causing partial obstruction of the right transverse sigmoid sinus. She agreed to undergo surgery for the left ventriculoperitoneal (VP) shunt placement, for management of her PTC. Postoperatively, the patient reported that her vision significantly improved. Patient 3 is a 49-year-old woman with history of meningioma who presented with left visual field cut. A right frontal VP shunt was recommended for the treatment of PTC. Postoperatively, the patient reported significant symptom improvement and resolution of visual complaints. This case series demonstrates that it is important to keep PTC in the differential diagnosis even when mass lesions such as meningiomas are discovered. Although PTC, as the name indicates, is classically diagnosed in patients without intracranial tumors, it is critical that this not be used as an absolute exclusion criterion. Finally, this case series supports the hypothesis that venous obstruction can result in PTC.
- 1 January 2018
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 9 (1) , 130
Open AccessPseudotumor cerebri comorbid with meningioma: A review and case series
Pseudotumor cerebri (PTC), which has a prevalence in the general population of 1 to 2 out of 100,000, presents with raised intracranial pressure (ICP) but generally lacks a space occupying lesion. Patient 1 is a 32-year-old woman with a history of multiple meningiomas. Upon presentation to our institution, her clinical exam was notable for a right sixth nerve palsy. An integrated diagnosis of PTC was made and shunting for the cerebrospinal fluid (CSF) diversion was recommended. Approximately 6 weeks after surgery, the patient exhibited complete symptom resolution and discontinued all medications. Patient 2 is a 40-year-old woman with history of meningioma causing partial obstruction of the right transverse sigmoid sinus. She agreed to undergo surgery for the left ventriculoperitoneal (VP) shunt placement, for management of her PTC. Postoperatively, the patient reported that her vision significantly improved. Patient 3 is a 49-year-old woman with history of meningioma who presented with left visual field cut. A right frontal VP shunt was recommended for the treatment of PTC. Postoperatively, the patient reported significant symptom improvement and resolution of visual complaints. This case series demonstrates that it is important to keep PTC in the differential diagnosis even when mass lesions such as meningiomas are discovered. Although PTC, as the name indicates, is classically diagnosed in patients without intracranial tumors, it is critical that this not be used as an absolute exclusion criterion. Finally, this case series supports the hypothesis that venous obstruction can result in PTC.
- 3 August 2014
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 18 (9) , 1-8
Headache and the Pseudotumor Cerebri Syndrome
Pseudotumor cerebri syndrome (PTCS) refers to the primary and secondary disorders that cause elevated intracranial pressure without an intracranial mass lesion, ventriculomegaly, or central nervous system infection or malignancy. Headache is the most frequent symptom of PTCS, but there is considerable overlap between the headache features of raised intracranial pressure and the headache features of primary headache disorders. We review headache subtypes that occur in PTCS, non-headache features that help distinguish PTCS from other headache types, changes to the diagnostic criteria for PTCS with and without papilledema, and headache treatment strategies as they apply to PTCS.
- 3 August 2014
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 18 (9) , 1-8
Headache and the Pseudotumor Cerebri Syndrome
Pseudotumor cerebri syndrome (PTCS) refers to the primary and secondary disorders that cause elevated intracranial pressure without an intracranial mass lesion, ventriculomegaly, or central nervous system infection or malignancy. Headache is the most frequent symptom of PTCS, but there is considerable overlap between the headache features of raised intracranial pressure and the headache features of primary headache disorders. We review headache subtypes that occur in PTCS, non-headache features that help distinguish PTCS from other headache types, changes to the diagnostic criteria for PTCS with and without papilledema, and headache treatment strategies as they apply to PTCS.
- 1 January 2011
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 5 (4) , 366-368
CHRONIC MYELOGENOUS LEUKEMIA AND RETINOPATHY TREATED WITH IMATINIB
Purpose: To describe a case of a rapid clinical response to treatment of leukemic retinopathy and optic nerve infiltration with cytoreductive therapy, including imatinib mesylate (Gleevec), without radiation therapy. Methods: Observational case report. Results: A 13-year-old boy presented with blurry vision and a visual acuity of 20/20 in each eye. On examination, he had infiltrative retinopathy and optic nerve elevation bilaterally. Further testing revealed chronic myelogenous leukemia with severe leukocytosis. The results of the bone marrow biopsy showed the Philadelphia chromosome, t(9;22), which indicated he might respond to imatinib. He was treated with leukopheresis, followed by systemic imatinib and hydroxyurea, and his leukemic retinopathy and optic neuropathy quickly improved. Conclusion: This case demonstrates an excellent clinical response to systemic therapy, including imatinib, without urgent radiation. It is possible, in select cases, to consider treatment with systemic cytoreductive therapy in patients with infiltrative optic neuropathy and retinopathy with the Philadelphia chromosome.
- 1 January 2011
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 5 (4) , 366-368
CHRONIC MYELOGENOUS LEUKEMIA AND RETINOPATHY TREATED WITH IMATINIB
Purpose: To describe a case of a rapid clinical response to treatment of leukemic retinopathy and optic nerve infiltration with cytoreductive therapy, including imatinib mesylate (Gleevec), without radiation therapy. Methods: Observational case report. Results: A 13-year-old boy presented with blurry vision and a visual acuity of 20/20 in each eye. On examination, he had infiltrative retinopathy and optic nerve elevation bilaterally. Further testing revealed chronic myelogenous leukemia with severe leukocytosis. The results of the bone marrow biopsy showed the Philadelphia chromosome, t(9;22), which indicated he might respond to imatinib. He was treated with leukopheresis, followed by systemic imatinib and hydroxyurea, and his leukemic retinopathy and optic neuropathy quickly improved. Conclusion: This case demonstrates an excellent clinical response to systemic therapy, including imatinib, without urgent radiation. It is possible, in select cases, to consider treatment with systemic cytoreductive therapy in patients with infiltrative optic neuropathy and retinopathy with the Philadelphia chromosome.
- Open Access
- 21 October 2010
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 74 (6) , 381-389
Pediatric Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)
Idiopathic intracranial hypertension (IIH), or pseudotumor cerebri, is a condition of elevated intracranial pressure in the absence of clinical, laboratory or radiological evidence of an intracranial space occupying lesion that can occur in the pediatric population. While IIH is more commonly recognized as a disorder of adults, it affects children of all ages and can have distinctive characteristics when presenting in the prepubertal age group. This review discusses the demographics, clinical presentation, diagnosis, neuroimaging, and management of pediatric IIH. Common etiologies of IIH in children, with particular focus on endocrine abnormalities, are highlighted.
- 21 October 2010
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 74 (6) , 381-389
Open AccessPediatric Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)
Idiopathic intracranial hypertension (IIH), or pseudotumor cerebri, is a condition of elevated intracranial pressure in the absence of clinical, laboratory or radiological evidence of an intracranial space occupying lesion that can occur in the pediatric population. While IIH is more commonly recognized as a disorder of adults, it affects children of all ages and can have distinctive characteristics when presenting in the prepubertal age group. This review discusses the demographics, clinical presentation, diagnosis, neuroimaging, and management of pediatric IIH. Common etiologies of IIH in children, with particular focus on endocrine abnormalities, are highlighted.
- 1 October 2006
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 17 (5) , 427-431
Optic gliomas of the anterior visual pathway
To review advances in the diagnosis and management of optic-pathway gliomas made within the past 5 years. Important papers regarding optic-pathway gliomas have been published recently in the following areas: neuroimaging, natural history and how the presence of neurofibromatosis type 1 affects it, unusual presentations, visual prognosis, and treatment with fractionated stereotactic radiotherapy. The diagnosis and treatment of optic-pathway gliomas has been aided greatly by a greater understanding of the natural history of these tumors and their prognosis related to the presence of neurofibromatosis type 1. Advances in magnetic resonance imaging are helping to delineate tumor extent. Newer radiation techniques that spare surrounding tissues are being used to treat optic-pathway gliomas, but chemotherapy has become the first-line treatment modality.
- 1 October 2006
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 17 (5) , 427-431
Optic gliomas of the anterior visual pathway
To review advances in the diagnosis and management of optic-pathway gliomas made within the past 5 years. Important papers regarding optic-pathway gliomas have been published recently in the following areas: neuroimaging, natural history and how the presence of neurofibromatosis type 1 affects it, unusual presentations, visual prognosis, and treatment with fractionated stereotactic radiotherapy. The diagnosis and treatment of optic-pathway gliomas has been aided greatly by a greater understanding of the natural history of these tumors and their prognosis related to the presence of neurofibromatosis type 1. Advances in magnetic resonance imaging are helping to delineate tumor extent. Newer radiation techniques that spare surrounding tissues are being used to treat optic-pathway gliomas, but chemotherapy has become the first-line treatment modality.
- 1 September 2006
- Vol. 27 (8) , 1628-1634
Magnocellular and Parvocellular Visual Pathways Have Different Blood Oxygen Level–Dependent Signal Time Courses in Human Primary Visual Cortex
PURPOSE: The magnocellular and parvocellular pathways (M and P pathways) are the major pathways of the visual system, with distinct histologic and physiologic properties that may also have different metabolic characteristics. We hypothesize that the differences of the 2 visual pathways would also manifest as differences in the signal time course of blood oxygen level–dependent functional MR imaging (BOLD fMRI). The differences in BOLD signal time course may provide insight into the metabolic requirements of the 2 pathways.
- 1 September 2006
- Vol. 27 (8) , 1628-1634
Magnocellular and Parvocellular Visual Pathways Have Different Blood Oxygen Level–Dependent Signal Time Courses in Human Primary Visual Cortex
PURPOSE: The magnocellular and parvocellular pathways (M and P pathways) are the major pathways of the visual system, with distinct histologic and physiologic properties that may also have different metabolic characteristics. We hypothesize that the differences of the 2 visual pathways would also manifest as differences in the signal time course of blood oxygen level–dependent functional MR imaging (BOLD fMRI). The differences in BOLD signal time course may provide insight into the metabolic requirements of the 2 pathways.
- 1 March 2004
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 137 (3) , 407-414
Optic radiation involvement in optic pathway gliomas in neurofibromatosis
- 1 March 2004
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 137 (3) , 407-414
Optic radiation involvement in optic pathway gliomas in neurofibromatosis
- 1 August 2002
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 4 (4) , 261-269
Pituitary adenomas
Treatment of pituitary adenomas can be pharmacologic or surgical. First-line treatment of prolactinomas is usually medical, using either bromocriptine or cabergoline. Other symptomatic pituitary adenomas typically should be treated with transsphenoidal surgery. Radiation therapy can be adjunctive for residual or recurrent tumor. The prognosis for endocrinologic and visual improvement is usually good.
- 1 August 2002
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 4 (4) , 261-269
Pituitary adenomas
Treatment of pituitary adenomas can be pharmacologic or surgical. First-line treatment of prolactinomas is usually medical, using either bromocriptine or cabergoline. Other symptomatic pituitary adenomas typically should be treated with transsphenoidal surgery. Radiation therapy can be adjunctive for residual or recurrent tumor. The prognosis for endocrinologic and visual improvement is usually good.
- 1 February 2002
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 6 (1) , 40-48
Eye dominance in the visual cortex using functional MRI at 1.5 T: An alternative method
- 1 February 2002
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 6 (1) , 40-48
Eye dominance in the visual cortex using functional MRI at 1.5 T: An alternative method